Fibroblast Interaction with Different Abutment Surfaces: In Vitro Study.

UV light abutment characteristics abutment integration bioactivation dental implant abutment fibroblast in vitro study plasma of argon

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
11 Mar 2020
Historique:
received: 30 01 2020
revised: 02 03 2020
accepted: 09 03 2020
entrez: 15 3 2020
pubmed: 15 3 2020
medline: 15 12 2020
Statut: epublish

Résumé

Attaining an effective mucosal attachment to the transmucosal part of the implant could protect the peri-implant bone. To evaluate if chair side surface treatments (plasma of Argon and ultraviolet light) may affect fibroblast adhesion on different titanium surfaces designed for soft tissue healing. Grade 5 titanium discs with four different surface topographies were subdivided into 3 groups: argon-plasma; ultraviolet light, and no treatment. Cell morphology and adhesion tests were performed at 20 min, 24 h, and 72 h. Qualitative observation of the surfaces performed at the SEM was in accordance with the anticipated features. Roughness values ranged from smooth (MAC Sa = 0.2) to very rough (XA Sa = 21). At 20 min, all the untreated surfaces presented hemispherical cells with reduced filopodia, while the cells on treated samples were more spread with broad lamellipodia. However, these differences in spreading behavior disappeared at 24 h and 72 h. Argon-plasma, but not UV, significantly increased the number of fibroblasts independently of the surface type but only at 20 min. Statistically, there was no surface in combination with a treatment that favored a greater cellular adhesion. Data showed potential biological benefits of treating implant abutment surfaces with the plasma of argon in relation to early-stage cell adhesion.

Sections du résumé

BACKGROUND BACKGROUND
Attaining an effective mucosal attachment to the transmucosal part of the implant could protect the peri-implant bone.
AIM OBJECTIVE
To evaluate if chair side surface treatments (plasma of Argon and ultraviolet light) may affect fibroblast adhesion on different titanium surfaces designed for soft tissue healing.
METHODS METHODS
Grade 5 titanium discs with four different surface topographies were subdivided into 3 groups: argon-plasma; ultraviolet light, and no treatment. Cell morphology and adhesion tests were performed at 20 min, 24 h, and 72 h.
RESULTS RESULTS
Qualitative observation of the surfaces performed at the SEM was in accordance with the anticipated features. Roughness values ranged from smooth (MAC Sa = 0.2) to very rough (XA Sa = 21). At 20 min, all the untreated surfaces presented hemispherical cells with reduced filopodia, while the cells on treated samples were more spread with broad lamellipodia. However, these differences in spreading behavior disappeared at 24 h and 72 h. Argon-plasma, but not UV, significantly increased the number of fibroblasts independently of the surface type but only at 20 min. Statistically, there was no surface in combination with a treatment that favored a greater cellular adhesion.
CONCLUSIONS CONCLUSIONS
Data showed potential biological benefits of treating implant abutment surfaces with the plasma of argon in relation to early-stage cell adhesion.

Identifiants

pubmed: 32168919
pii: ijms21061919
doi: 10.3390/ijms21061919
pmc: PMC7139398
pii:
doi:

Substances chimiques

Argon 67XQY1V3KH
Titanium D1JT611TNE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : Dipartimenti di Eccellenza ex L.232/2016

Références

J Clin Periodontol. 1996 Oct;23(10):971-3
pubmed: 8915028
Int J Periodontics Restorative Dent. 2010 Jun;30(3):245-55
pubmed: 20386781
Clin Oral Implants Res. 2014 Sep;25(9):997-1003
pubmed: 23799997
Acta Biomater. 2013 Apr;9(4):6268-77
pubmed: 23232211
Stem Cells Int. 2017;2017:6202783
pubmed: 28572824
Cell Death Differ. 2018 Mar;25(3):573-588
pubmed: 29229999
J Dent Res. 2016 May;95(5):566-73
pubmed: 26848069
Int J Prosthodont. 2015 Jul-Aug;28(4):389-95
pubmed: 26218023
Int J Oral Maxillofac Implants. 2018 May/Jun;33(3):571-579
pubmed: 29763495
Clin Oral Implants Res. 2007 Feb;18(1):1-8
pubmed: 17224016
Clin Oral Implants Res. 2014 Sep;25(9):1041-50
pubmed: 23782316
J Mater Sci Mater Med. 2010 Oct;21(10):2751-63
pubmed: 20725770
Clin Oral Implants Res. 2006 Oct;17 Suppl 2:68-81
pubmed: 16968383
J Biosci Bioeng. 2011 Mar;111(3):255-8
pubmed: 21288768
Eur J Oral Sci. 2018 Apr;126(2):126-134
pubmed: 29336070
Clin Oral Implants Res. 2017 Oct;28(10):1269-1277
pubmed: 27552929
J Biomed Mater Res A. 2009 Jun 15;89(4):942-50
pubmed: 18470920
Int J Periodontics Restorative Dent. 2012 Oct;32(5):497-507
pubmed: 22754897
Int J Periodontics Restorative Dent. 2012 Aug;32(4):385-92
pubmed: 22577643
Acta Biomater. 2014 Jul;10(7):2894-906
pubmed: 24590162
J Clin Periodontol. 1999 Oct;26(10):658-63
pubmed: 10522777
J Biomed Mater Res A. 2019 Jan;107(1):67-70
pubmed: 30358073
J Clin Periodontol. 2013 Aug;40(8):807-15
pubmed: 23725491
Int J Mol Sci. 2018 Feb 09;19(2):
pubmed: 29425177
J Periodontol. 2007 Sep;78(9):1657-63
pubmed: 17760532
Stem Cells Int. 2016;2016:4968724
pubmed: 28018432
Int J Periodontics Restorative Dent. 2008 Apr;28(2):111-21
pubmed: 18546807
Int J Oral Maxillofac Implants. 2017 Nov/Dec;32(6):1315-1323
pubmed: 29140375
Clin Oral Implants Res. 2008 May;19(5):491-6
pubmed: 18416727
Int J Oral Maxillofac Implants. 2018 Nov/Dec;33(6):1247-1254
pubmed: 30427955
Clin Oral Implants Res. 2014 May;25(5):573-9
pubmed: 23406227
Clin Oral Implants Res. 2014 Mar;25(3):328-336
pubmed: 23210704
J Biomed Mater Res A. 2005 Jul 1;74(1):49-58
pubmed: 15924300
Clin Oral Implants Res. 2006 Oct;17 Suppl 2:55-67
pubmed: 16968382
Clin Implant Dent Relat Res. 2015 Dec;17(6):1237-49
pubmed: 25066589
Clin Implant Dent Relat Res. 2005;7 Suppl 1:S44-51
pubmed: 16137087
J Cell Biol. 2017 Jul 3;216(7):2107-2130
pubmed: 28550110
Front Physiol. 2019 Oct 14;10:1291
pubmed: 31681005
Colloids Surf B Biointerfaces. 2014 Feb 1;114:284-93
pubmed: 24216619
Clin Oral Implants Res. 2008 Jul;19(7):635-41
pubmed: 18492075
ACS Appl Mater Interfaces. 2018 Nov 21;10(46):39512-39523
pubmed: 30359523
Int J Periodontics Restorative Dent. 2007 Jun;27(3):211-9
pubmed: 17694944
Int J Mol Sci. 2018 May 14;19(5):
pubmed: 29757956
Clin Oral Implants Res. 2017 Sep;28(9):e121-e134
pubmed: 27492799
Am J Hematol. 2019 Jan;94(1):10-20
pubmed: 30252956
Clin Oral Implants Res. 2009 Sep;20 Suppl 4:172-84
pubmed: 19663964
Cancers (Basel). 2019 Jun 01;11(6):
pubmed: 31159426
Sci Rep. 2017 Aug 22;7(1):9068
pubmed: 28831175
J Clin Periodontol. 2012 Apr;39(4):400-7
pubmed: 22324415
J Dent Res. 2006 Jun;85(6):496-500
pubmed: 16723643
Int J Periodontics Restorative Dent. 2017 Jul/Aug;37(4):541-548
pubmed: 28609500
Int J Periodontics Restorative Dent. 2010 Apr;30(2):129-37
pubmed: 20228972

Auteurs

Luigi Canullo (L)

Private Practice, Via Nizza, 46, 00198 Rome, Italy.

Tullio Genova (T)

Department of Life Sciences and Systems Biology, University of Torino, 10126 Turin, Italy.
CIR Dental School-Department of Surgical Sciences, University of Torino, Via Nizza 230, 10126 Turin, Italy.

Esperanza Gross Trujillo (E)

Department of Buccofacial Prosthesis, University Complutense, 28040 Madrid, Spain.

Guillermo Pradies (G)

Department of Buccofacial Prosthesis, University Complutense, 28040 Madrid, Spain.

Sara Petrillo (S)

Department of Molecular Biotechnology and Health Sciences, University of Rome III, 00133 Rome, Italy.

Maurizio Muzzi (M)

Department of Science, University of Rome III, 00133 Rome, Italy.

Stefano Carossa (S)

CIR Dental School-Department of Surgical Sciences, University of Torino, Via Nizza 230, 10126 Turin, Italy.

Federico Mussano (F)

CIR Dental School-Department of Surgical Sciences, University of Torino, Via Nizza 230, 10126 Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH